8:17 AM ET
8-K
M&A Deal
Organon & M&A Deal with Sun Pharmaceutical Industries Limited
Organon & Co. provided a status update on its pending merger with Sun Pharmaceutical Industries Limited, noting that it has suspended customary earnings calls and press releases due to the transaction. The company furnished supplemental non-GAAP financial metrics for the third quarter of 2026 in lieu of a formal earnings release while the merger remains active.
- Counterparty
- Sun Pharmaceutical Industries Limited